Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 19.35 | 12.01 | 9.61 | 5.12 |
Depreciation/ Depletion | 3.35 | 3.55 | 2.47 | 1.99 |
Non- Cash Items | 8.50 | 6.24 | 1.43 | 0.81 |
Changesin Working Capital | -31.35 | -19.21 | -7.73 | 37.74 |
Cashfrom Operating Activities | -0.15 | 2.59 | 5.78 | 45.66 |
Capital Expenditures | -6.45 | -3.81 | -8.20 | -36.30 |
Other Investing Cash Flow Items Total | -3.09 | 11.73 | -7.05 | -1.27 |
Cashfrom Investing Activities | -9.54 | 7.92 | -15.25 | -37.57 |
Financing Cash Flow Items | -4.50 | -4.98 | 5.64 | -0.64 |
Issuance( Retirement)of Stock Net | 3.86 | 2.50 | 0.09 | 0.06 |
Issuance( Retirement)of Debt Net | 9.45 | 1.76 | 2.50 | 2.19 |
Cashfrom Financing Activities | 8.81 | -0.72 | 7.03 | 1.61 |
Net Changein Cash | -0.88 | 9.78 | -2.44 | 9.70 |
Cash Taxes Paid | 7.04 | 4.33 | 2.54 | 1.01 |
Total Cash Dividends Paid | - | - | -1.20 | - |
Cash Interest Paid | - | - | - | 0.75 |
Kilitch Drugs India Dividend Kilitch Drugs India Bonus Kilitch Drugs India News Kilitch Drugs India AGM Kilitch Drugs India Rights Kilitch Drugs India Splits Kilitch Drugs India Board Meetings Kilitch Drugs India Key Metrics Kilitch Drugs India Shareholdings Kilitch Drugs India Profit Loss Kilitch Drugs India Balance Sheet Kilitch Drugs India Q1 Results Kilitch Drugs India Q2 Results Kilitch Drugs India Q3 Results Kilitch Drugs India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks